- Home
- ZM vs PODD Comparison
ZM vs PODD Comparison
Compare ZM & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZM | PODD |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.0B | 22.1B |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ZM | PODD |
|---|---|---|
| Price | $87.53 | $304.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 19 |
| Target Price | $92.19 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 3.4M | 765.6K |
| Earning Date | 11-24-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.29 | N/A |
| EPS | ★ 5.13 | 3.45 |
| Revenue | ★ $4,805,915,000.00 | $2,521,800,000.00 |
| Revenue This Year | $6.70 | $32.55 |
| Revenue Next Year | $3.35 | $20.39 |
| P/E Ratio | ★ $17.09 | $88.24 |
| Revenue Growth | 3.85 | ★ 27.11 |
| 52 Week Low | $64.41 | $230.05 |
| 52 Week High | $91.04 | $354.88 |
Technical Indicators
Market Signals| Indicator | ZM | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 62.23 | 40.94 |
| Support Level | $83.99 | $303.20 |
| Resistance Level | $86.98 | $317.34 |
| Average True Range (ATR) | 2.70 | 13.12 |
| MACD | 0.55 | -2.82 |
| Stochastic Oscillator | 75.00 | 3.14 |
Price Performance
Historical ComparisonAbout ZM Zoom Video Communications Inc.
Zoom Video Communications provides a communications platform that connects people through video, voice, chat, and content sharing. The company's cloud-native platform enables face-to-face video and connects users across various devices and locations in a single meeting. Zoom, which was founded in 2011 and is headquartered in San Jose, California, serves companies of all sizes from all industries around the world.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.